Cargando…

1722. Histoplasmosis Acquired in Alberta, Canada, 2011–2018

BACKGROUND: Histoplasmosis is a serious fungal infection caused by the geographically restricted, dimorphic fungus Histoplasma capsulatum. In Canada, the geographic range of H. capsulatum is classically thought to be restricted to southern parts of Ontario and Quebec. Over the past decade, histoplas...

Descripción completa

Detalles Bibliográficos
Autores principales: Dingle, Tanis, Fathima, Sumana, Sonpar, Ashlesha, Saxinger, Lynora M, Schwartz, Ilan S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809391/
http://dx.doi.org/10.1093/ofid/ofz360.1585
_version_ 1783461976372936704
author Dingle, Tanis
Fathima, Sumana
Sonpar, Ashlesha
Saxinger, Lynora M
Schwartz, Ilan S
author_facet Dingle, Tanis
Fathima, Sumana
Sonpar, Ashlesha
Saxinger, Lynora M
Schwartz, Ilan S
author_sort Dingle, Tanis
collection PubMed
description BACKGROUND: Histoplasmosis is a serious fungal infection caused by the geographically restricted, dimorphic fungus Histoplasma capsulatum. In Canada, the geographic range of H. capsulatum is classically thought to be restricted to southern parts of Ontario and Quebec. Over the past decade, histoplasmosis has occasionally been diagnosed in patients in Alberta without travel to areas of known geographic risk (Figure 1). We studied the epidemiology and geographic distribution of histoplasmosis in Alberta to assess evidence for locally-acquired infections. METHODS: We retrospectively reviewed all laboratory-confirmed (culture, antigen and/or immunodiffusion positive) cases of histoplasmosis diagnosed from January 1, 2011 to June 30, 2018. Data collected by public health and clinical charts were reviewed for clinical presentation, exposure and travel histories, and geographic distribution of cases. Cases of histoplasmosis in patients who had not left Alberta or associated with a local point source were classified as definite local acquisition; cases in patients with remote travel but with local exposures and appropriate timing of disease onset were deemed “probable” cases of local infection. University of Alberta’s Research Ethics Board approved this study. RESULTS: We identified 45 laboratory-confirmed cases of histoplasmosis, including 17 cases that were locally acquired. Among these, there were 12 cases of definite local acquisition, including 8 patients from 3 point-source outbreaks—all involving exposure to bats and/or their droppings in chimneys or attics of private dwellings or churches—and 4 sporadic cases in patients who had never traveled. Of the other 5 cases probably acquired in Alberta, patients had previously traveled (n = 4) or travel history was incomplete (n = 1) but local exposures preceding infection were considered compelling. The mean incidence rate of locally acquired infection was 0.062/100,000 population with incidence increasing since 2014. Table 1 shows features of locally acquired cases. CONCLUSION: This study, for the first time, establishes Alberta as a region of geographic risk for histoplasmosis. The diagnosis should be considered in patients with compatible symptoms and exposure history, even in the absence of travel. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6809391
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-68093912019-10-28 1722. Histoplasmosis Acquired in Alberta, Canada, 2011–2018 Dingle, Tanis Fathima, Sumana Sonpar, Ashlesha Saxinger, Lynora M Schwartz, Ilan S Open Forum Infect Dis Abstracts BACKGROUND: Histoplasmosis is a serious fungal infection caused by the geographically restricted, dimorphic fungus Histoplasma capsulatum. In Canada, the geographic range of H. capsulatum is classically thought to be restricted to southern parts of Ontario and Quebec. Over the past decade, histoplasmosis has occasionally been diagnosed in patients in Alberta without travel to areas of known geographic risk (Figure 1). We studied the epidemiology and geographic distribution of histoplasmosis in Alberta to assess evidence for locally-acquired infections. METHODS: We retrospectively reviewed all laboratory-confirmed (culture, antigen and/or immunodiffusion positive) cases of histoplasmosis diagnosed from January 1, 2011 to June 30, 2018. Data collected by public health and clinical charts were reviewed for clinical presentation, exposure and travel histories, and geographic distribution of cases. Cases of histoplasmosis in patients who had not left Alberta or associated with a local point source were classified as definite local acquisition; cases in patients with remote travel but with local exposures and appropriate timing of disease onset were deemed “probable” cases of local infection. University of Alberta’s Research Ethics Board approved this study. RESULTS: We identified 45 laboratory-confirmed cases of histoplasmosis, including 17 cases that were locally acquired. Among these, there were 12 cases of definite local acquisition, including 8 patients from 3 point-source outbreaks—all involving exposure to bats and/or their droppings in chimneys or attics of private dwellings or churches—and 4 sporadic cases in patients who had never traveled. Of the other 5 cases probably acquired in Alberta, patients had previously traveled (n = 4) or travel history was incomplete (n = 1) but local exposures preceding infection were considered compelling. The mean incidence rate of locally acquired infection was 0.062/100,000 population with incidence increasing since 2014. Table 1 shows features of locally acquired cases. CONCLUSION: This study, for the first time, establishes Alberta as a region of geographic risk for histoplasmosis. The diagnosis should be considered in patients with compatible symptoms and exposure history, even in the absence of travel. [Image: see text] [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6809391/ http://dx.doi.org/10.1093/ofid/ofz360.1585 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Dingle, Tanis
Fathima, Sumana
Sonpar, Ashlesha
Saxinger, Lynora M
Schwartz, Ilan S
1722. Histoplasmosis Acquired in Alberta, Canada, 2011–2018
title 1722. Histoplasmosis Acquired in Alberta, Canada, 2011–2018
title_full 1722. Histoplasmosis Acquired in Alberta, Canada, 2011–2018
title_fullStr 1722. Histoplasmosis Acquired in Alberta, Canada, 2011–2018
title_full_unstemmed 1722. Histoplasmosis Acquired in Alberta, Canada, 2011–2018
title_short 1722. Histoplasmosis Acquired in Alberta, Canada, 2011–2018
title_sort 1722. histoplasmosis acquired in alberta, canada, 2011–2018
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809391/
http://dx.doi.org/10.1093/ofid/ofz360.1585
work_keys_str_mv AT dingletanis 1722histoplasmosisacquiredinalbertacanada20112018
AT fathimasumana 1722histoplasmosisacquiredinalbertacanada20112018
AT sonparashlesha 1722histoplasmosisacquiredinalbertacanada20112018
AT saxingerlynoram 1722histoplasmosisacquiredinalbertacanada20112018
AT schwartzilans 1722histoplasmosisacquiredinalbertacanada20112018